UNSPSC 51286101: Enoxamast

This classification denotes an anti-asthmatic agent with the molecular formula C13H10N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 08703R750L, chemically known as (4-(1,4-benzodioxan-6-yl)-2-thiazolyl)oxamic acid. but more generally known as enoxamast, which bears US NIH Compound Identifier 194595. European Medicines Agency schedules Enoxamast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06541MIG.

The term ENOXAMAST is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 39, No. 5, 1985, List 25). ENOXAMAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S1CC(NC1NC(=O)C(=O)O)C1CC2OCCOC2CC1.

UNSPSC 51286101 Enoxamast, a Commodity code, captures state and local procurement of pharmaceutical products and medical supplies, though the recent opportunities show divergence from the code's nominal scope. State and local governments use this code to solicit naloxone and opioid-response systems, emergency medical consumables including respiratory equipment and cardiac monitoring devices, generic pharmaceuticals and over-the-counter products, and therapeutic pharmacy program supplies. Issuing bodies span county health departments, city fire and rescue divisions, state health and human services agencies, and cooperative purchasing alliances representing multi-state and multi-jurisdictional participation. The mix reflects both direct health and emergency-response procurement and aggregated purchasing vehicles serving multiple member jurisdictions through authorized wholesalers.

Recent activity concentrates in Florida and Minnesota, with cross-state participation through cooperative purchasing arrangements. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for delivery to the Seminole County Community Health Building, with a response deadline of July 26, 2026 and a fixed-fee contract structure. The City of Tampa issued an ITB (26P00145) on March 25, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a response deadline of March 13, 2026; this procurement is sheltered for certified Small Local Business Enterprises with a 5% bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP (S1070000015802) on January 20, 2026, to establish contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026. The Texas Health and Human Services Commission issued a Request for Information (RFI HHS0017013) on April 3, 2026, to gather vendor capabilities for a Direct-to-Manufacturer Prescriptions program, representing an exploratory procurement phase prior to formal solicitation.